Open AccessSmall-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment
Author(s) -
Leiming Wang,
Chiang-Min Cheng,
Jun Qin,
Mafei Xu,
ChungYang Kao,
Jingjing Shi,
Erli You,
Wanchun Gong,
Laura Pedro Rosa,
Peter Chase,
Louis Scampavia,
Franck Madoux,
Timothy Spicer,
Peter Hodder,
H. Eric Xu,
Sophia Y. Tsai,
MingJer Tsai
Publication year - 2020
Publication title -
science advances
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 5.928
H-Index - 146
ISSN - 2375-2548
DOI - 10.1126/sciadv.aaz8031
Subject(s) - prostate cancer , cancer research , nuclear receptor , cancer , transcription factor , foxa1 , orphan receptor , biology , medicine , pharmacology , gene , genetics
We identified inhibitors targeting COUP-TFII for the treatment of diseases including prostate cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom